FNY Investment Advisers, LLC

Position in CLGN — CollPlant Biotechnologies Ltd

CIK 1742998 NEW YORK, NY

Position in CLGN

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$1,832

+$1,830 QoQ

Shares Held

5,250

-0.9% QoQ

Ownership

0.028%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#10

of 15 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $19,945,542 across 57 Biotechnology names. CLGN ranks #46 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1			108,951	$13,455,448
2	ABVX	Abivax S.A.	7,605	$1,013,442
3	SGMT	Sagimet Biosciences Inc.	109,250	$844,502
4	APGE	Apogee Therapeutics, Inc.	5,000	$663,650
5	JANX	Janux Therapeutics, Inc.	30,850	$473,856
6	NKTR	Nektar Therapeutics	5,500	$383,955
7	VERU	Veru Inc.	105,081	$328,903
8	VKTX	Viking Therapeutics, Inc.	8,170	$318,711

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,832	5,250	-0.9%	Shares	Sole	2026-07-08
2026-03-31	$2	5,300	+1.0%	Shares	Sole	2026-04-15
2025-12-31	$7,350	5,250	0.0%	Shares	Sole	2026-01-16
2025-09-30	$14,122	5,250	+241.1%	Shares	Sole	2025-12-15
2023-12-31	$9,834	1,539	0.0%	Shares	Sole	2024-01-12
2023-09-30	$8,572	1,539	0.0%	Shares	Sole	2023-10-10
2023-06-30	$12,558	1,539	-70.7%	Shares	Sole	2023-07-11
2022-09-30	$35,700	5,250	+5.0%	Shares	Sole	2022-10-19
2022-06-30	$40,000	5,000	0.0%	Shares	Sole	2022-07-12
2022-03-31	$56,100	5,000	+150.0%	Shares	Sole	2022-04-25
2021-12-31	$32,720	2,000	-50.0%	Shares	Sole	2022-02-01
2021-09-30	$67,600	4,000	0.0%	Shares	Sole	2021-10-13
2021-06-30	$84,840	4,000	—	Shares	Sole	2021-07-14
No filing history on record for this holder in this stock.